Dukes Jonathan W, Dewland Thomas A, Vittinghoff Eric, Mandyam Mala C, Heckbert Susan R, Siscovick David S, Stein Phyllis K, Psaty Bruce M, Sotoodehnia Nona, Gottdiener John S, Marcus Gregory M
Cardiac Electrophysiology Section, Division of Cardiology, Department of Medicine, University of California, San Francisco, California.
Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon.
J Am Coll Cardiol. 2015 Jul 14;66(2):101-9. doi: 10.1016/j.jacc.2015.04.062.
Studies of patients presenting for catheter ablation suggest that premature ventricular contractions (PVCs) are a modifiable risk factor for congestive heart failure (CHF). The relationship among PVC frequency, incident CHF, and mortality in the general population remains unknown.
The goal of this study was to determine whether PVC frequency ascertained using a 24-h Holter monitor is a predictor of a decrease in the left ventricular ejection fraction (LVEF), incident CHF, and death in a population-based cohort.
We studied 1,139 Cardiovascular Health Study (CHS) participants who were randomly assigned to 24-h ambulatory electrocardiography (Holter) monitoring and who had a normal LVEF and no history of CHF. PVC frequency was quantified using Holter studies, and LVEF was measured from baseline and 5-year echocardiograms. Participants were followed for incident CHF and death.
Those in the upper quartile versus the lowest quartile of PVC frequency had a multivariable-adjusted, 3-fold greater odds of a 5-year decrease in LVEF (odds ratio [OR]: 3.10; 95% confidence interval [CI]: 1.42 to 6.77; p = 0.005), a 48% increased risk of incident CHF (HR: 1.48; 95% CI: 1.08 to 2.04; p = 0.02), and a 31% increased risk of death (HR: 1.31; 95% CI: 1.06 to 1.63; p = 0.01) during a median follow-up of >13 years. Similar statistically significant results were observed for PVCs analyzed as a continuous variable. The specificity for the 15-year risk of CHF exceeded 90% when PVCs included at least 0.7% of ventricular beats. The population-level risk for incident CHF attributed to PVCs was 8.1% (95% CI: 1.2% to 14.9%).
In a population-based sample, a higher frequency of PVCs was associated with a decrease in LVEF, an increase in incident CHF, and increased mortality. Because of the capacity to prevent PVCs through medical or ablation therapy, PVCs may represent a modifiable risk factor for CHF and death.
针对接受导管消融术患者的研究表明,室性早搏(PVC)是充血性心力衰竭(CHF)的一个可改变的危险因素。在一般人群中,PVC频率、CHF发生率和死亡率之间的关系尚不清楚。
本研究的目的是确定使用24小时动态心电图监测确定的PVC频率是否可预测基于人群队列中的左心室射血分数(LVEF)降低、CHF发生及死亡情况。
我们研究了1139名心血管健康研究(CHS)参与者,他们被随机分配接受24小时动态心电图(Holter)监测,且LVEF正常且无CHF病史。通过Holter研究对PVC频率进行量化,并从基线和5年超声心动图测量LVEF。对参与者进行CHF发生及死亡情况随访。
在中位数随访时间超过13年期间,PVC频率处于上四分位数的人群与最低四分位数人群相比,LVEF在5年内降低的多变量调整后优势比高3倍(优势比[OR]:3.10;95%置信区间[CI]:1.42至6.77;p = 0.005),CHF发生风险增加48%(风险比[HR]:1.48;95% CI:1.08至2.04;p = 0.02),死亡风险增加31%(HR:1.31;95% CI:1.06至1.63;p = 0.01)。将PVC作为连续变量分析时,观察到类似的统计学显著结果。当PVC至少占心室搏动的0.7%时,CHF 15年风险的特异性超过90%。归因于PVC的CHF人群水平风险为8.1%(95% CI:1.2%至14.9%)。
在基于人群的样本中,较高的PVC频率与LVEF降低、CHF发生率增加及死亡率增加相关。由于通过药物或消融治疗有能力预防PVC,PVC可能是CHF和死亡的一个可改变的危险因素。